pirfenidone has been researched along with Colorectal Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alaei, M; Asghari, SZ; Asgharzadeh, F; Avan, A; Babaei, F; Ferns, GA; Fiuji, H; Hassanian, SM; Jamialahmadi, H; Khalili-Tanha, G; Khazaei, M; Khojasteh-Leylakoohi, F; Maftooh, M; Mansouri, S; Mirahmadi, M; Nazari, SE; Saburi, E; TanzadehPanah, H | 1 |
| Chen, C; Jing, L; Liu, Y; Sun, X; Wang, H; Wen, G; Xu, Y; Yao, X; Zhang, Q; Zhao, L | 1 |
2 other study(ies) available for pirfenidone and Colorectal Neoplasms
| Article | Year |
|---|---|
Targeting transforming growth factor beta (TGF-β) using Pirfenidone, a potential repurposing therapeutic strategy in colorectal cancer.
Topics: Cadherins; Colorectal Neoplasms; Fluorouracil; Humans; Pyridones; Tumor Microenvironment | 2023 |
Dahuang Zhechong Pill suppresses colorectal cancer liver metastasis via ameliorating exosomal CCL2 primed pre-metastatic niche.
Topics: Antineoplastic Agents, Phytogenic; Chemokine CCL2; Colorectal Neoplasms; Drugs, Chinese Herbal; Gene Expression Regulation, Neoplastic; Humans; Liver Cirrhosis; Liver Neoplasms; Macrophages; Neoplasm Metastasis; Neoplasms, Experimental; Pyridones; Pyrrolidinones; Receptors, CCR2 | 2019 |